Sheldon R - Search Results

1

Historical criteria that distinguish syncope from seizures.

Sheldon R, Rose S, Ritchie D, Connolly SJ, Koshman ML, Lee MA, Frenneaux M, Fisher M, Murphy W. Sheldon R, et al. J Am Coll Cardiol. 2002 Jul 3;40(1):142-8. doi: 10.1016/s0735-1097(02)01940-x. J Am Coll Cardiol. 2002. PMID: 12103268 Free article.

2

Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia.

Chiamvimonvat N, Mitchell LB, Gillis AM, Wyse DG, Sheldon RS, Duff HJ. Chiamvimonvat N, et al. Among authors: sheldon rs. Am J Cardiol. 1992 Sep 1;70(6):598-604. doi: 10.1016/0002-9149(92)90198-8. Am J Cardiol. 1992. PMID: 1324598

3

Right and left ventricular function during chronic amiodarone therapy.

Sheldon RS, Mitchell LB, Duff HJ, Wyse DG, Manyari DE. Sheldon RS, et al. Am J Cardiol. 1988 Oct 1;62(10 Pt 1):736-40. doi: 10.1016/0002-9149(88)91213-1. Am J Cardiol. 1988. PMID: 3421174

4

Characteristics of patients with nonfatal cardiac arrest 3 to 180 days after acute myocardial infarction.

Sheldon RS, Wyse DG, Mitchell LB, Gillis AM, Kavanagh KM, Duff HJ. Sheldon RS, et al. Am J Cardiol. 1993 Oct 1;72(11):753-8. doi: 10.1016/0002-9149(93)91057-o. Am J Cardiol. 1993. PMID: 8213505

5

A prospective randomized comparison of autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease.

Gillis AM, Leitch JW, Sheldon RS, Morillo CA, Wyse DG, Yee R, Klein GJ, Mitchell LB. Gillis AM, et al. Among authors: sheldon rs. Am J Cardiol. 1993 Nov 15;72(15):1146-51. doi: 10.1016/0002-9149(93)90984-k. Am J Cardiol. 1993. PMID: 8237804 Clinical Trial.

6

Canadian Implantable Defibrillator Study (CIDS): study design and organization. CIDS Co-Investigators.

Connolly SJ, Gent M, Roberts RS, Dorian P, Green MS, Klein GJ, Mitchell LB, Sheldon RS, Roy D. Connolly SJ, et al. Among authors: sheldon rs. Am J Cardiol. 1993 Nov 26;72(16):103F-108F. doi: 10.1016/0002-9149(93)90972-f. Am J Cardiol. 1993. PMID: 8237822 Clinical Trial.

7

Risks of developing supraventricular and ventricular tachyarrhythmias after implantation of a cardioverter-defibrillator, and timing the activation of arrhythmia termination therapies.

Hii JT, Gillis AM, Wyse DG, Sheldon RS, Duff HJ, Mitchell LB. Hii JT, et al. Among authors: sheldon rs. Am J Cardiol. 1993 Mar 1;71(7):565-8. doi: 10.1016/0002-9149(93)90512-b. Am J Cardiol. 1993. PMID: 8438742

8

Abnormal reflex venous function in patients with neuromediated syncope.

Manyari DE, Rose S, Tyberg JV, Sheldon RS. Manyari DE, et al. Among authors: sheldon rs. J Am Coll Cardiol. 1996 Jun;27(7):1730-5. doi: 10.1016/0735-1097(96)00051-4. J Am Coll Cardiol. 1996. PMID: 8636561 Free article.

9

North American Vasovagal Pacemaker Study: study design and organization.

Sheldon RS, Gent M, Roberts RS, Connolly SJ. Sheldon RS, et al. Pacing Clin Electrophysiol. 1997 Mar;20(3 Pt 2):844-8. doi: 10.1111/j.1540-8159.1997.tb03919.x. Pacing Clin Electrophysiol. 1997. PMID: 9080525 Clinical Trial.

10

Definition of predicted effective antiarrhythmic drug therapy for ventricular tachyarrhythmias by the electrophysiologic study approach: randomized comparison of patient response criteria.

Mitchell LB, Sheldon RS, Gillis AM, Connolly SJ, Duff HJ, Gardner MJ, Hui WK, Ramadan D, Wyse DG. Mitchell LB, et al. Among authors: sheldon rs. J Am Coll Cardiol. 1997 Nov 1;30(5):1346-53. doi: 10.1016/s0735-1097(97)00294-5. J Am Coll Cardiol. 1997. PMID: 9350938 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

696 results

Search Page

Filters